Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis

BACKGROUND: To explore the activity of pazopanib (P) + sirolimus (S) in patients who progressed after previous clinical benefit on pazopanib. METHODS: Eight patients with progressing metastatic high grade soft tissue sarcoma (STS) whose disease advanced on P following a response duration of at least...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, D., Azraq, Y., Eleyan, F., Gill, S., Peretz, T., Merimsky, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977830/
https://www.ncbi.nlm.nih.gov/pubmed/27501793
http://dx.doi.org/10.1186/s12885-016-2618-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977830/
https://www.ncbi.nlm.nih.gov/pubmed/27501793
http://dx.doi.org/10.1186/s12885-016-2618-1

Ejemplares similares